Literature DB >> 24277212

Pyrrolo(l ,4)benzodiazepine Antitumor Antibiotics: Chemistry, Interaction with DNA, and Biological Implications.

L H Hurley1, D E Thurston.   

Abstract

The pyrrolo(l,4)benzodiazepine (P(1,4)B) antitumor antibiotics, anthramycin, tomaymycin, sibiromycin and the neothramycins A and B, are potent anticancer agents that form covalent adducts through the exocyclic amino group of guanine in DNA. This review describes the chemistry important for both the DNA reactivity and synthesis of the carbinolamine containing drugs and the strategy for elucidation of the three-dimensional form of the adduct with DNA. The high DNA sequence specificity as well as some of the observed biological consequences of DNA damage caused by these agents in human and yeast cells are rationalized through the proposed structure of the drug-DNA adducts. Parallel toxicological studies have led to a proposal for the underlying mechanism for the cardiotoxicity of certain members of this group of agents. A rationale for designing drugs which should retain their potent antitumor activity without the associated cardiotoxicity is also proposed. Lastly, the application of the P(l,4)B's as probes for monitoring drug binding to DNA and drug-induced conformational changes is described.

Entities:  

Year:  1984        PMID: 24277212     DOI: 10.1023/A:1016395113085

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  42 in total

1.  Biosynthesis of anthramycin. Determination of the labeling pattern by the use of radioactive and stable isotope techniques.

Authors:  L H Hurley; M Zmijewski; C J Chang
Journal:  J Am Chem Soc       Date:  1975-07-23       Impact factor: 15.419

2.  Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin.

Authors:  J Goodman; P Hochstein
Journal:  Biochem Biophys Res Commun       Date:  1977-07-25       Impact factor: 3.575

Review 3.  Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin.

Authors:  L H Hurley
Journal:  J Antibiot (Tokyo)       Date:  1977-05       Impact factor: 2.649

4.  In vitro and in vivo stability of anthramycin-DNA conjugate and its potential application as an anthramycin prodrug.

Authors:  L H Hurley; C S Allen; J M Feola; W C Lubawy
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

5.  Studies on the mechanism of action of anthramycin methyl ether, a new antitumor antibiotic.

Authors:  H M Bates; W Kuenzig; W B Watson
Journal:  Cancer Res       Date:  1969-12       Impact factor: 12.701

6.  The structure of anthramycin.

Authors:  W Leimgruber; A D Batcho; F Schenker
Journal:  J Am Chem Soc       Date:  1965-12-20       Impact factor: 15.419

7.  CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity.

Authors:  D G Martin; C Biles; S A Gerpheide; L J Hanka; W C Krueger; J P McGovren; S A Mizsak; G L Neil; J C Stewart; J Visser
Journal:  J Antibiot (Tokyo)       Date:  1981-09       Impact factor: 2.649

8.  Mutagenic and recombinogenic effects of the antitumor antibiotic anthramycin.

Authors:  M A Hannan; L H Hurley; C Gairola
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

9.  Studies on tomaymycin. II. Total syntheses of the antitumor antibiotics, E-and Z-tomaymycins.

Authors:  Z Tozuka; H Takasugi; T Takaya
Journal:  J Antibiot (Tokyo)       Date:  1983-03       Impact factor: 2.649

10.  Altered physiochemical properties of the deoxyribonucleic acid-mitomycin C complex. Evidence for the conformational change in deoxyribonucleic acid.

Authors:  D J Kaplan; M Tomasz
Journal:  Biochemistry       Date:  1982-06-08       Impact factor: 3.162

View more
  6 in total

1.  Identification of the dioxygenase-generated intermediate formed during biosynthesis of the dihydropyrrole moiety common to anthramycin and sibiromycin.

Authors:  Shalini Saha; Wei Li; Barbara Gerratana; Steven E Rokita
Journal:  Bioorg Med Chem       Date:  2014-12-20       Impact factor: 3.641

Review 2.  Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.

Authors:  Alicia J Angelbello; Jonathan L Chen; Jessica L Childs-Disney; Peiyuan Zhang; Zi-Fu Wang; Matthew D Disney
Journal:  Chem Rev       Date:  2018-01-11       Impact factor: 60.622

3.  Genome mining of Streptomyces sp. BRB081 reveals the production of the antitumor pyrrolobenzodiazepine sibiromycin.

Authors:  Vida M B Leite; Leandro M Garrido; Marcelo M P Tangerina; Leticia V Costa-Lotufo; Marcelo J P Ferreira; Gabriel Padilla
Journal:  3 Biotech       Date:  2022-08-27       Impact factor: 2.893

4.  A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis.

Authors:  Herman Tse; Qiangshuai Gu; Kong-Hung Sze; Ivan K Chu; Richard Y-T Kao; Kam-Chung Lee; Ching-Wan Lam; Dan Yang; Sherlock Shing-Chiu Tai; Yihong Ke; Elaine Chan; Wan-Mui Chan; Jun Dai; Sze-Pui Leung; Suet-Yi Leung; Kwok-Yung Yuen
Journal:  J Biol Chem       Date:  2017-09-26       Impact factor: 5.157

5.  Dissociation of minor groove binders from DNA: insights from metadynamics simulations.

Authors:  Attilio Vittorio Vargiu; Paolo Ruggerone; Alessandra Magistrato; Paolo Carloni
Journal:  Nucleic Acids Res       Date:  2008-09-18       Impact factor: 16.971

6.  Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.

Authors:  Emily E Bosco; R James Christie; Rosa Carrasco; Darrin Sabol; Jiping Zha; Karma DaCosta; Lee Brown; Maureen Kennedy; John Meekin; Sandrina Phipps; Joanne Ayriss; Qun Du; Binyam Bezabeh; Partha Chowdhury; Shannon Breen; Cui Chen; Molly Reed; MaryJane Hinrichs; Haihong Zhong; Zhan Xiao; Rakesh Dixit; Ronald Herbst; David A Tice
Journal:  Oncotarget       Date:  2018-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.